PEOPLE - diaDexus (US) makes appointment:
This article was originally published in Clinica
Executive Summary
diaDexus, the US diagnostics joint venture between SmithKline Beecham and Incyte Pharmaceuticals, has named Dr George Poste acting CEO. Dr Poste, who replaces Dr William Gerber, will continue in his current role as diaDexus' chairman and SmithKline Beecham's chief science and technology officer.